Hemispherx Biopharma (HEB) Reports Q3 Loss of $0.30/Share
Get Alerts HEB Hot Sheet
Join SI Premium – FREE
Hemispherx Biopharma (NYSE: HEB) reported Q3 EPS of ($0.30), versus ($0.62) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma (HEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- BCB Bancorp (BCBP) Misses Q1 EPS by 2c
- Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!